© 2020 MJH Life Sciences and Practical Cardiology. All rights reserved.
© 2020 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
September 04, 2020
Deepak Bhatt, MD, of Brigham and Women's Hospital, offers perspective on REDUCE-IT analyses and icosapent ethyl (Vascepa) data presented at ESC Congress 2020.
September 03, 2020
Milton Packer, MD, discusses how EMPEROR-Reduced data influences the way clinicians view the SGLT2 inhibitor class and its uses.
August 18, 2020
Gregory Weiss, MD, offers his perspective on a recent scientific statement from the American Heart Association underlining the importance of dietary assessments in patients seeing a cardiologist.
August 10, 2020
A new scientific statement from the American Heart Association is acting as a "call to action" for greater research into the effects of marijuana, according to the statement's co-author.
August 06, 2020
Analysis of PEGASUS-TIMI 54 patients indicates incorporating the biomarker into guideline-based risk assessment could improve risk classification and care.
August 03, 2020
A new network meta-analysis offers an overview of the clinical benefit of less than 6 months, 6-month, 12-month, and extended periods of DAPT therapy after PCI with drug-eluting stents.
April 02, 2019
In 2018, the American College of Cardiology and American Heart Association teamed up to update treatment guidelines for atherosclerotic cardiovascular disease. Learn more in this recap.
March 26, 2019
The American College of Cardiology and the American Heart Association have updated treatment recommendations for the primary prevention of cardiovascular disease. Among the recommendations: Stop recommending aspirin to prevent CVD.